Applications of Alzheimer's disease staging to clinical trials

Aging (Albany NY). 2023 Jan 5;15(1):4-5. doi: 10.18632/aging.204482. Epub 2023 Jan 5.

Authors

Joseph Therriault^{1

2

3}, Serge Gauthier^{1

2}, Pedro Rosa-Neto^{1

2

3}

Affiliations

¹ Translational Neuroimaging Laboratory, The McGill University Research Centre for Studies in Aging, Douglas Hospital, McGill University, Canada.
² Department of Neurology and Neurosurgery, McGill University, Canada.
³ Montreal Neurological Institute, Canada.

No abstract available

Keywords: Alzheimer’s disease; biomarkers; clinical trials; disease staging; tau.

Publication types

Editorial

MeSH terms

Alzheimer Disease*
Amyloid beta-Peptides
Biomarkers
Humans
tau Proteins

Substances

tau Proteins
Amyloid beta-Peptides
Biomarkers